Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
•
General Rheumatology
•
Dermatology
•
Hidradenitis Suppurativa
How would you manage a patient with hidradenitis suppurativa and inflammatory arthritis (RA vs. PsA)?
Pt has not responded to Humira or Cosentyx. Pt is declining to have any infusion options.
Related Questions
Can Xolair (omalizumab) be safely used in combination with biologics for patients with rheumatic disease?
How do you approach managing nausea and GI side effects when initiating methotrexate?
Can Dupixent (dupliumab) be safely used in patients who are taking other biologics for rheumatic disease?
How do you approach use of DMARDs and/or biologics for inflammatory arthritis in patients with a history of seizure disorder on anti-epileptic medications?
How do you counsel and manage joint pain after isotretinoin treatment?
How do you approach medication management in patients with RA when transitioning from csDMARD triple therapy to anti-TNF?
How would you approach management of a patient with longstanding history of SLE, but having active psoriasis?
What is your approach to work up for patients referred for early onset osteoarthritis?
What is the maximum dose of leucovorin that you use with methotrexate?
How would you approach management of a young male patient with discoid lupus who has had minimal response to hydroxychloroquine (and subtherapeutic whole blood levels) who continues to use tobacco products?